MEG3 and lung cancer: The MEG3 was also able to reverse cisplatin‐tolerance of lung adenocarcinoma cells by inducing cell apoptosis,15 and silencing of MEG3, conversely, improved cisplatin‐resistance of non‐small cell lung cancer cells via activation of WNT/β‐catenin signaling.16